Feasibility and nutritional impact of laparoscopic assisted tailored subtotal gastrectomy for middle-third gastric cancer

Table 1 Clinical characteristics of patients in the laparoscopic-assisted tailored subtotal gastrectomy and laparoscopic assisted total gastrectomy groups

Characteristic	LaTSG (n = 47)	LaTG (n = 45)	P value
Sex (M/F)	11/36	17/28	0.175
Age	57.0 ± 11.1	58.0 ± 9.9	0.571
BMI (kg/m2)	23.6 ± 3.4	23.7 ± 3.0	0.559
ASA-PS (1/2/3)	2/44/1	2/42/1	0.998
pT stage			0.027
pT1	18 (38.3)	10 (22.2)
pT2	5 (10.6)	4 (8.9)
pT3	8 (17.0)	22 (48.9)
pT4a	16 (34.0)	9 (20.0)
pN stage			0.371
pN0	23 (48.9)	14 (31.2)
pN1	10 (21.3)	14 (31.2)
pN2	6 (12.8)	7 (15.6)
pN3	8 (17.0)	10 (22.2)
pTNM stage			0.217
I	18 (38.3)	11 (24.4)
II	10 (21.3)	16 (35.6)
III	19 (40.4)	18 (40.0)
Previous abdominal operation	4 (8.5)	1 (2.2)	0.362
Neoadjuvant chemotherapy	9 (19.1)	6 (13.3)	0.575
Histological type			0.237
Signet-ring cell carcinoma	20 (42.6)	12 (26.7)	0.187
Blood vessel invasion	30 (63.9)	30 (66.6)	0.829
Neural infiltration	26 (55.4)	27 (60.0)	0.532
Tumor location			0.604
Lesser curvature	25 (53.2)	24 (53.4)
Middle	3 (6.4)	5 (11.1)
Middle and low	19 (40.4)	16 (35.6)

LaTSG: Laparoscopic-assisted tailored subtotal gastrectomy; LaTG: Laparoscopic assisted total gastrectomy; BMI: Body mass index; ASA-PS: American Society of Anesthesiologists Physical Status Classification.